Related Experiment Video
Updated: Jun 12, 2026

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
Published on: December 23, 2022
Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas
Mohammed Soutto1, Dunfa Peng, Mohammad Razvi
1Department of Surgery, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37323, USA.
Background:
The checkpoint with forkhead-associated domain and RING-finger domain (CHFR) is a mitotic checkpoint protein with tumor-suppressor functions. In this study, the authors investigated the epigenetic and genetic mechanisms that regulate CHFR expression in esophageal adenocarcinomas (EACs).
Methods:
Quantitative reverse transcriptase polymerase chain reaction analysis demonstrated downregulation of CHFR transcript in 79% of EACs (44 of 56) compared with 41 normal samples (P < .001). Immunohistochemical analysis of CHFR protein expression showed absence or weak immunostaining for CHFR in 75% of EACs (56 of 75) compared with normal tissue samples. The authors next examined the promoter DNA hypermethylation of CHFR by using quantitative bisulfite pyrosequencing technology. They detected significant CHFR promoter DNA hypermethylation in 31% of tumor samples (18 of 58) compared with normal samples (P < .001). Treatment of OE33 cells with 5-Aza-deoxycytidine led to reduction in the promoter DNA methylation levels with restoration of the CHFR mRNA expression, which confirmed promoter DNA methylation as an epigenetic mechanism regulating CHFR expression. However, they identified several EACs where the CHFR mRNA expression was silenced in the absence of notable methylation. Therefore, the authors examined the relative DNA copy number level of CHFR compared with normal samples.
Results:
The results confirmed a decrease or absence of the relative CHFR DNA copy number levels in 59% of tumor samples. Nine tumors that showed loss of CHFR mRNA expression, in absence of promoter DNA hypermethylation, demonstrated a significant loss of relative CHFR DNA copy numbers.
Conclusions:
Taken together, their findings demonstrated that both epigenetic and genetic mechanisms were involved in silencing CHFR expression in EACs.
Insights
Checkpoint with forkhead-associated domain and RING-finger domain (CHFR) expression is silenced in esophageal adenocarcinomas by both epigenetic DNA hypermethylation and genetic DNA copy number loss.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The checkpoint with forkhead-associated domain and RING-finger domain (CHFR) is a crucial mitotic checkpoint protein with demonstrated tumor-suppressor functions.
- Dysregulation of CHFR is implicated in various cancers, highlighting its importance in maintaining genomic stability.
Purpose of the Study:
- To investigate the epigenetic and genetic mechanisms responsible for regulating CHFR expression in esophageal adenocarcinomas (EACs).
- To determine the frequency and interplay of DNA hypermethylation and copy number alterations in CHFR silencing in EACs.
Main Methods:
- Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and immunohistochemistry (IHC) were used to assess CHFR transcript and protein levels.
- Quantitative bisulfite pyrosequencing was employed to analyze CHFR promoter DNA methylation.
- DNA copy number analysis was performed to evaluate genetic alterations of the CHFR locus.
Main Results:
- CHFR transcript was downregulated in 79% of EACs, with absent or weak protein expression in 75%.
- Significant CHFR promoter DNA hypermethylation was detected in 31% of EACs, and its reduction with 5-Aza-deoxycytidine restored CHFR mRNA expression.
- Loss or decrease of CHFR DNA copy number was observed in 59% of EACs, with nine tumors showing copy number loss in the absence of promoter hypermethylation.
Conclusions:
- Both epigenetic silencing via promoter DNA hypermethylation and genetic mechanisms involving DNA copy number loss contribute to the downregulation of CHFR expression in esophageal adenocarcinomas.
- These findings elucidate the multifaceted regulation of CHFR in EAC development and progression.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Inheritance of Chromatin Structures
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the timing and level of...
